Edwards Lifesciences

Edwards Lifesciences, a leading U.S. medical device company, has reportedly reached an agreement to sell its intensive care unit (ICU) business to fellow U.S. firm BD for USD 4.2 billion. This strategic move is accompanied by a global restructuring that will result in layoffs impacting approximately 3% of the company’s…